I agree that this site is using cookies. You can find further informations here.
X
Faessel, Hélène
53  results:
Search for persons X
?
1

Safety and pharmacodynamics of a single infusion of danavor..:

Bogan, Richard K. ; Maynard, James P. ; Neuwirth, Rachel...
Sleep Medicine.  107 (2023)  - p. 229-235 , 2023
Link: https://doi.org/10.1016/..
 
?
2

Orexin 2 receptor‐selective agonist danavorexton (TAK‐925) ..:

Evans, Rebecca ; Kimura, Haruhide ; Nakashima, Masato...
Journal of Sleep Research.  32 (2023)  5 - p. , 2023
Link: https://doi.org/10.1111/..
 
?
3

Safety and pharmacodynamics of a single infusion of danavor..:

Mignot, Emmanuel ; Bogan, Richard K ; Emsellem, Helene...
SLEEP.  46 (2023)  9 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
4

Orexin 2 receptor–selective agonist danavorexton improves n..:

Evans, Rebecca ; Kimura, Haruhide ; Alexander, Robert...
Proceedings of the National Academy of Sciences.  119 (2022)  35 - p. , 2022
Link: https://doi.org/10.1073/..
 
?
5

Pevonedistat in East Asian patients with acute myeloid leuk..:

Handa, Hiroshi ; Cheong, June-Won ; Onishi, Yasushi...
Journal of Hematology & Oncology.  15 (2022)  1 - p. , 2022
Link: https://doi.org/10.1186/..
 
?
6

Safety, tolerability, pharmacokinetics, pharmacodynamics, b..:

Wang, Shining ; Chen, Grace ; Merlo Pich, Emilio...
British Journal of Clinical Pharmacology.  87 (2021)  11 - p. 4354-4365 , 2021
Link: https://doi.org/10.1111/..
 
?
7

A Phase I, Randomized, Double‐Blind, Placebo‐Controlled, Si..:

Esfandiari, Ehsanollah ; Chen, Mary ; Smithson, Glennda...
Clinical and Translational Science.  14 (2021)  3 - p. 820-828 , 2021
Link: https://doi.org/10.1111/..
 
?
8

Effect of CYP3A inhibitors on the pharmacokinetics of pevon..:

Faessel, Hélène ; Nemunaitis, John ; Bauer, Todd M....
British Journal of Clinical Pharmacology.  85 (2019)  7 - p. 1464-1473 , 2019
Link: https://doi.org/10.1111/..
 
?
9

Phase Ib study of pevonedistat, a NEDD8-activating enzyme i..:

Lockhart, A Craig ; Bauer, Todd M. ; Aggarwal, Charu...
Investigational New Drugs.  37 (2018)  1 - p. 87-97 , 2018
Link: https://doi.org/10.1007/..
 
?
10

A phase I study of the investigational NEDD8-activating enz..:

Bhatia, Shailender ; Pavlick, Anna C. ; Boasberg, Peter...
Investigational New Drugs.  34 (2016)  4 - p. 439-449 , 2016
Link: https://doi.org/10.1007/..
 
?
11

Pevonedistat (MLN4924), a First‐in‐Class NEDD8‐activating e..:

Swords, Ronan T. ; Erba, Harry P. ; DeAngelo, Daniel J....
British Journal of Haematology.  169 (2015)  4 - p. 534-543 , 2015
Link: https://doi.org/10.1111/..
 
?
12

P1‐264: H3 receptor antagonism increases methylhistamine le..:

Soares, Holly ; Wager, Travis T. ; Schmidt, Anne W....
Alzheimer's & Dementia.  5 (2009)  4S_Part_8 - p. , 2009
Link: https://doi.org/10.1016/..
 
?
13

Pharmacokinetics, safety, and tolerability of varenicline i..:

Faessel, Helene ; Ravva, Patanjali ; Williams, Kathryn
Clinical Therapeutics.  31 (2009)  1 - p. 177-189 , 2009
Link: https://doi.org/10.1016/..
 
?
14

The Search for Cytotoxic Synergy Between Anticancer Agents:..:

Greco, William R. ; Faessel, Hélène ; Levasseur, Laurence
JNCI: Journal of the National Cancer Institute.  88 (1996)  11 - p. 699-700 , 1996
Link: https://doi.org/10.1093/..
 
?
15

Pharmacokinetics, pharmacodynamics and safety assessment of..:

Wang, Shining ; Chen, Grace ; Merlo Pich, Emilio...
British Journal of Clinical Pharmacology.  88 (2022)  6 - p. 2899-2908 , 2022
Link: https://doi.org/10.1111/..
 
1-15